Subtype
Uterine Corpus Neoplasm
CI-CAN-00007035Explore in graph →
Non-malignant451 active trials4 approved drugs28 evidence items
- NCIt
- C6300
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00007035Explore in graph →
Clinical trials
1,714 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05261165 | Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | completed | — | 170 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT01979003 | Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion | completed | Early Phase 1 | 100 | University of ArkansasOTHER | 1 | Feb 24, 2022 |
| clinicaltrials |
| NCT02728258 | Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer | completed | Phase 2 | 11 | NRG OncologyOTHER | 1 | Feb 15, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 | clinicaltrials |
| NCT01307631 | Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2022 | clinicaltrials |
| NCT03317795 | Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids | completed | Phase 4 | 18 | Shannon K. Laughlin-TommasoOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT01759355 | Hybrid PET/MR in the Therapy of Cervical Cancer | completed | — | 18 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 3, 2021 | clinicaltrials |
| NCT01512810 | Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer | completed | Phase 2 | 200 | Frederick R. Ueland, M.D.OTHER | 1 | Nov 24, 2021 | clinicaltrials |
| NCT02315469 | Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery | completed | — | 190 | NRG OncologyOTHER | 2 | Nov 24, 2021 | clinicaltrials |
| NCT02725268 | A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer | completed | Phase 2 | 241 | Millennium Pharmaceuticals, Inc.INDUSTRY | 10 | Nov 24, 2021 | clinicaltrials |
| NCT03018249 | Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04030182 | Vitamin D Deficit in Women With Uterine Fibroids | completed | — | 127 | Instituto Mexicano del Seguro SocialOTHER_GOV | 1 | Nov 8, 2021 | clinicaltrials |
| NCT00063999 | Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer | completed | Phase 3 | 1,381 | GOG FoundationNETWORK | 3 | Oct 19, 2021 | clinicaltrials |
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab(PROLOG) | completed | Phase 1 | 12 | The Netherlands Cancer InstituteOTHER | 1 | Oct 19, 2021 | clinicaltrials |
| NCT03276013 | Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer(TOPIC) | completed | Phase 2 | 48 | Vall d'Hebron Institute of OncologyOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04672421 | The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study) | completed | N/A | 107 | Shin Poong Pharmaceutical Co. Ltd.INDUSTRY | 1 | Sep 29, 2021 | clinicaltrials |
| NCT04819633 | Evaluating Serum Sestrin in Leiomyoma Patients | completed | — | 61 | Sisli Hamidiye Etfal Training and Research HospitalOTHER | 1 | Sep 21, 2021 | clinicaltrials |
| NCT03962140 | CT Assessment of BMI in Endometrial Cancer Patients | completed | — | 302 | Royal Cornwall Hospitals TrustOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT02226302 | Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer(FETCH) | completed | — | 16 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Sep 9, 2021 | clinicaltrials |
| NCT03192059 | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer(PRIMMO) | completed | Phase 2 | 43 | University Hospital, GhentOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT02058550 | Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy | completed | Phase 1 | 72 | Stanford UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT04068675 | Effects of Centering Pre-operative Counseling on Patient Reported Anxiety | completed | N/A | 75 | Northwestern UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT03722030 | Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors | completed | N/A | 40 | University of Wisconsin, MadisonOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | completed | Phase 1 / Phase 2 | 141 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 11, 2021 | clinicaltrials |
| NCT03820024 | MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback(MOVES) | completed | N/A | 39 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 29, 2021 | clinicaltrials |
| NCT01738152 | Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health | completed | N/A | 106 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT00731341 | Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata | completed | N/A | 3 | Boston Scientific CorporationINDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT01441635 | Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids | completed | Phase 2 | 271 | AbbVie (prior sponsor, Abbott)INDUSTRY | 0 | Jul 13, 2021 | clinicaltrials |
| NCT02925494 | An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids | completed | Phase 3 | 433 | AbbVieINDUSTRY | 3 | Jul 13, 2021 | clinicaltrials |
| NCT03070899 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 1) | completed | Phase 3 | 526 | ObsEva SAINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04917341 | The Compatibility of Preoperative Endometrial Biopsies With Postoperative Final Pathology in Endometrial Cancer | completed | — | 960 | Batman Training and Research HospitalOTHER_GOV | 0 | Jun 8, 2021 | clinicaltrials |
| NCT02269293 | Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers | completed | Phase 1 | 23 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2021 | clinicaltrials |
| NCT01065662 | AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | completed | Phase 1 | 11 | Susana M. Campos, MDOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | completed | N/A | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT04830332 | Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology | completed | N/A | 50 | Erdemli State HospitalOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03908996 | the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer | completed | N/A | 25 | Sanford HealthOTHER | 1 | Mar 18, 2021 | clinicaltrials |
| NCT03070951 | Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids(PRIMROSE 2) | completed | Phase 3 | 511 | ObsEva SAINDUSTRY | 9 | Mar 5, 2021 | clinicaltrials |
| NCT03824613 | Urinary miRNA in Endometrial Cancer Study | completed | — | 164 | Royal Cornwall Hospitals TrustOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03021720 | Satisfaction of Patients With Trans-Arterial Radial Access: Quality of Life in Uterine Fibroid Embolization Trial(SPARQLE) | completed | N/A | 40 | Mount Sinai Hospital, CanadaOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03444987 | The Role of Fibroblast Activation in Uterine Fibroid | completed | — | 35 | Assiut UniversityOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT02725489 | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers | completed | Phase 2 | 13 | Mary Crowley Medical Research CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT01840124 | Uterine Leiomyoma Treatment With Radiofrequency Ablation(ULTRA) | completed | N/A | 26 | University of California, San FranciscoOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT01338831 | Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer | completed | Phase 1 | 73 | Novartis PharmaceuticalsINDUSTRY | 4 | Dec 17, 2020 | clinicaltrials |
| NCT02506816 | Preoperative Olaparib Endometrial Carcinoma Study (POLEN)(Polen) | completed | — | 36 | MedSIROTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT03241914 | Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer | completed | Phase 2 / Phase 3 | 64 | Fudan UniversityOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT02260752 | Patient Centered Results for Uterine Fibroids(COMPARE-UF) | completed | — | 3,094 | Duke UniversityOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT00879840 | Assessment of Screening Modalities for Gynecologic Cancers | completed | — | 118 | National Cancer Institute (NCI)NIH | 1 | Nov 17, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Mar 2, 2022source: clinicaltrials